drugset / Trial / NCT01783977

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

NCT01783977

RandomizedParallel-groupQuadruple-blindPrevention

Summary

NOTE: This study has stopped enrolling new participants, and all study vaccinations for currently enrolled participants have been stopped. Currently, there are no vaccines approved for the prevention of HIV infection, but there are many clinical trials taking place that are studying experimental HIV vaccines. The purpose of this study is to evaluate the safety and tolerability of three different HIV vaccine schedules in healthy, HIV-uninfected adults.

Timeline

Start
2013-04
Primary completion
2014-09
Completion
2018-10-24

Drugs

EvaluationDrugModalityDoseRoute
Subject DNA-HIV-PT123 Vaccine 1 ml Intramuscular
Subject NYVAC-HIV-PT1 Vaccine 1 ml Intramuscular
Subject NYVAC-HIV-PT4 Vaccine 1 ml Intramuscular